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Abstract
Leucine supplementation and resistance training positively influence the protein translation process and the cell signaling mTOR (mammalian target of
rapamycin) pathway that regulates muscle protein balance and muscle remodeling, and thus may be therapeutic to diabetic myopathy. However, the effect
of a combined intervention has not been well studied. Forty male Wistar rats
were divided into five groups, control (C), diabetic control (D), diabetic +
trained (DT), diabetic + L-leucine (DL), diabetic + L-leucine + trained (DLT).
The supplementation of 5% leucine in chow, and resistance training were conducted for 8 weeks postweaning of rats. The extensor digitorum longus was
used to assess signaling proteins involved in muscle protein synthesis, and the
gastrocnemius and soleus were used for determination of muscle weight.
Blood samples were collected for biochemical assays. Strength and ambulation
tests were employed to evaluate motor performance. Results showed that both
leucine supplementation and resistance training elevated the activity of
mTOR-p70S6K in diabetic rats (P < 0.05). Moreover, though leucine supplementation in combination with resistance training demonstrated synergistic
effects on p70S6K (P < 0.05), both treatments were capable of recovering
motor performance (P < 0.05). In conclusion, 5% leucine supplementation
combined with resistance training has the potential to attenuate muscle loss
and motor performance decrements in diabetic rats, at least in part through
increased protein synthesis.

Physiol Rep, 5 (10), 2017, e13273,
https://doi.org/10.14814/phy2.13273

Introduction
Diabetes mellitus is a chronic inflammatory disease that
affects nearly every biological process including an altered
protein metabolism, decreased muscle mass, and in some
cases, impaired ability to carry out daily activities,
decreased productivity and diminished quality of life
(Workeneh and Bajaj 2013). While the development of
each form of diabetes (type 1 or type 2) drastically differs,
resultant pathologies often overlap. In each diabetic condition, a failure to maintain healthy muscle is often

observed, and this is termed diabetic myopathy (D’Souza
et al. 2013; Krause et al. 2013).
Attenuating the effects of diabetes can be challenging,
but recent studies provide important insights into the cellular and molecular etiology of diabetes-associated
decreases in muscle mass, and these findings may be useful in the development of new therapies for the disease
(Gumucio and Mendias 2013). In addition, studies have
shown that leucine supplementation and resistance training confer an anabolic effect by stimulating the beginning
of the protein translation process and the cell signaling
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pathway known as mTOR (mammalian target of rapamycin), thereby promoting positive effects on strength gains,
muscle mass, protein balance, and preservation of functional capacity (Hurley and Roth 2000; Castaneda et al.
2002; Dreyer et al. 2006).
Resistance training induces an increase in muscle protein synthesis (MPS) that can last for 48 h postexercise
(Phillips et al. 1997) and the repetitive strain of regimented weekly sessions promotes a positive protein balance that can lead to substantial accretion of muscle
proteins over time. A positive protein balance requires
that the rate of MPS exceeds the rate of muscle protein
breakdown (MPB) (Burd et al. 2009). Hypertrophy of
skeletal muscle and the resulting concomitant gain in
strength are of great interest for people with diseaseinduced atrophy. There is evidence that resistance training
can stimulate and reinforce cellular and molecular processes that lead to a compensatory hypertrophy response
in this population (Haddad and Adams 2002). Moreover,
resistance training has been shown to augment insulin
signaling and glucose transport in skeletal muscle tissue
(Takala et al. 1999; Holloszy 2005).
The intake of dietary protein after resistance training
increases plasma amino acids, which results in the activation of signaling molecules leading to increased MPS and
muscle hypertrophy (Phillips 2014). Although essential
amino acids are necessary for hypertrophy, L-leucine has
been specifically shown to activate mTOR and increase
the initiation of the translation of protein synthesis
(Guimar~aes-ferreira et al. 2014). On the other hand, the
hypothesized beneficial effects of leucine supplementation
for the treatment of diabetes mellitus are related to the
improvement of energy balance, net protein balance, and
glucose homeostasis (Pedroso et al. 2015).
In order to better elucidate the actions of leucine supplementation and resistance training (alone or combined)
on muscle remodeling processes, the purpose of this study
was to investigate the chronic effects of these interventions on muscle atrophy in an experimental model of diabetes mellitus induced by streptozotocin (STZ).

Materials and methods
Animals
Five-day-old male Wistar Hannover rats were separated
from their mothers for 8 h. They were divided into two
groups: the diabetic group (D group) received an ip injection of STZ [120 mg/kg body weight (b.w.)] freshly diluted
in citrate buffer [10 mmol/L Na citrate (pH 4.5)]; and the
nondiabetic group (non-D group) received only the vehicle
(ip) in an equivalent volume and served as control [control
group (C group)] (n = 8). After weaning, rats from the D
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group were divided into four groups: D group (D, n = 8)
received an isonitrogenous control diet; DT group (DT,
n = 8) received an isonitrogenous control diet and performed resistance training; DL group (DL, n = 8) was treated with 5% L-leucine; and DLT group (DLT, n = 8) was
treated with 5% of L-leucine and resistance training. After
weaning, the animals presenting glycemia above 150 mg/dl
were included in this study.
The animals were obtained from the Animal House of
the Faculty of Pharmaceutical Sciences, University of Sao
Paulo and the experiments were performed according to
the ethical guidelines adopted by the Brazilian College of
Animal Experimentation (protocol 451). The animals were
maintained in individual cages under standard conditions
of light (12-h light/dark cycle), temperature (22  2°C)
and relative humidity (55  10%), and with full access to
food (American Institute of Nutrition) and water. The
body weight, food intake and water intake were registered
three times per week from weaning to killing (12-weekold). All animals were adapted to the laboratory environment for 1 week, before engaging in the training program.
Animals were euthanized under tiletamine-zolazepam and
fentanyl anesthesia at 48 h after the last resistance training
session and with a 6-h fast. The extensor digitorum longus
muscle (EDL), gastrocnemius (GAS), soleus (SOL) muscles
of each limb were isolated, weighed, and frozen at 80°C.
The protein concentration in EDL muscle homogenate was
determined with a BCA protein assay kit (Thermo Scientific, Rockford, IL, USA).

Diets
The experimental diets were prepared according to the
recommendations of the American Institute of Nutrition
(Reeves et al. 1993). After weight distribution, rats were
fed either the control diet (C group), an isonitrogenous
control diet (D and DT group), or a leucine-rich diet
(DL and DLT group) for 8 weeks. 5% of L-leucine was
added to the intervention diet by replacing equal amounts
of corn flour, while the isonitrogenous control diet contained an additional 4% of nonessential amino acids
(Table 1). The nonessential amino acids meal was used as
the control diet to standardize the nitrogen (Vianna et al.
2012). The supplemental dose of 5% L-leucine was used
because it has been shown in previous work to positively
regulate MPS (Rieu et al. 2003). Other research used this
leucine dose with no toxic effects reported (Tsubuku
et al. 2004).

Resistance training protocol
The resistance training protocol was adapted from Hornberger and Farrar (2004), which consisted of climbing a
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Table 1. Diet composition1 (%).

Ingredients
Cornstarch
Casein
Sucrose
Soybean oil
Cellulose
Mineral mixture
Vitamin mixture
L-cystine
Choline bitartrate
Tert-butyl
hydroquinone
Leucine
NEAAs

Basal
diet

Leucine-rich
diet

Isonitrogenous
control diet

62%
14%
10%
4%
5%
3%
1%
1%
0.2%
0.0008%

57%
14%
10%
4%
5%
3%
1%
1%
0.2%
0.0008%

58%
14%
10%
4%
5%
3%
1%
1%
0.2%
0.0008%

0%
0%

5%
0%

0%
4%

NEAAs- isonitrogenous mixture of nonessential amino acids
(alanine, aspartate, glutamate, glycine, proline, and serine).
1
Based on AIN-93M (Reeves et al. 1993).

vertical ladder (1.1 9 0.18 m, 2 cm grid, 80° inclined)
with progressive loads secured to the base of the rats tail,
as described below. The load apparatus was secured to
the tail by wrapping the proximal portion of the tail with
a self-adhesive foam strip. A Velcro strap was wrapped
around the foam strip and fastened. With the load apparatus secured to the tail, the rats were placed at the bottom of the ladder and familiarized with climbing. The
initial climb consisted of carrying a load that was 75% of
the animal’s body mass. After this, an additional 30 g
weight was added until a load was reached with which
the rat could not climb the entire length of the ladder.
Failure was determined when the animal could not progress up the ladder after three successive stimuli to the
tail. The highest load successfully carried the entire length
of the ladder was considered the rat’s maximal carrying
capacity for that training session. Training sessions were 9
ladder climbs with 75%, 90%, and 100% of the rat’s previous maximal carrying capacity, determined earlier. During subsequent ladder climbs, an additional 30 g load was
added until a new maximal carrying capacity was
determined.

Motor performance tests functional
assessment
In order to evaluate skeletal muscle function, the animals
were allowed to grab onto the Grip Strength System
(model: DFE-002, San Diego Instruments, San Diego, Cal,
USA) with their forepaws as the experimenter gently
pulled on their tails. The result is the maximal force
before the animal releases the forepaws of the bar (mean

of three measurements of maximum pull) (Anderson
et al. 2004; Nalbandian et al. 2013).
The second motor performance test was the ambulation test, which was performed to determine the mean
length and width (cm) of a step measured in hind foot
ink prints while mice freely ran along a corridor (length:
100 cm; width: 10.5 cm; height of lateral walls: 20 cm)
three different times. Before the test, the animals were
permitted to explore the apparatus (Kennel et al. 1996;
Zanchi et al. 2012). Mean values were individually calculated for each test through the mean of three consecutive
tests performed.

Serum glucose and insulin levels
Blood was collected and centrifuged in order to obtain
the serum fractions. Serum was stored at 80°C for further analysis. Serum glucose was measured using commercial available kits (Labtest). Serum insulin levels
were measured using commercial RECYTMAG-65k
MILLIPLEX MAP rat cytoquine/chemoquine magnetic
bead.

Western blot analysis
Initially, frozen EDL muscle in ice-cold lysis buffer:
50 mmol/L phosphate buffer (pH 7.0), 0.3 mol/L sucrose,
0.5 mmol/L dithiothreitol, 1 mmol/L EDTA, 0.3 mmol/L
PMSF, 10 mmol/L NaF, 1:100 Phosphatase Inhibitor
Cocktail 1–2 (Sigma-Aldrich, St. Louis, MO) and 1:100
Protease Inhibitor Cocktail (Sigma-Aldrich) using a polytron homogenizer. After homogenization and transfer to
new prechilled tubes, samples were centrifuged at 13,000g
for 25 min at 4°C. Supernatants were collected and total
protein concentrations were measured using a BCA protein assay kit (Pierce, Rockford, IL). Lysates were combined with a sample buffer: 240 mmol/L Tris (pH 6.8),
40% glycerol, 0.8% sodium dodecyl sulfate (SDS),
200 mmol/L beta-mercaptoethanol, and 0.02% bromophenol blue. Proteins (25 lg) were subjected to SDS
polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membrane. Membranes were blocked with
5% bovine serum albumin (BSA) and phosphate buffered
saline with tween (PBST) and were incubated overnight
at 4°C with rabbit polyclonal antibodies (Cell Signaling
Technology, Beverly, MA) diluted in PBST buffer: antimTOR diluted 1:1000, anti-pmTOR (Ser2448) diluted
1:1000, anti-S6K1 diluted 1:1000, anti-pS6K1 (Thr389)
diluted 1:1000. Membranes were incubated for 1 h with
horseradish-peroxidase-labeled antirabbit IgG antibodies
(Sigma-Aldrich) diluted 1:1000 in PBST buffer and 1%
BSA. Blots were visualized for 5 min in an ImageQuant
400 (GE Healthcare, Amersham, UK) image system with
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a solution prepared with ECL-Advance Western blotting
Reagent (GE Healthcare). After densitometry, phosphorylated proteins were normalized by total protein content.
A horseradish-peroxidase-labeled anti-b-actin (SigmaAldrich) diluted 1:40,000 was used in order to verify correct protein loading.

Statistical analysis
Statistical analysis was performed using GraphPad Prism
software 6.0 (GraphPad Software, Inc., San Diego, CA).
2-way ANOVA test with repeated measures followed by
Tukey’s test was used for comparison of weekly evolution
of body weight and (time 9 group) of functional performance tests, and 1-way ANOVA followed by Tukey’s test
for food and water intake, muscle weight, glucose and
insulin and western blot analysis. The a priori significance
level was set at P < 0.05. The results are expressed as
means  SEM.

Results
Body weight
The body weight of nontreated diabetic rats (D group)
was reduced in final time course of 8 weeks when compared with nondiabetic rats (C group) (P < 0.05).
Interestingly, the body weight of groups (DT, DL and
DLT) that received treatment was not significantly different when compared with group C (P > 0.05)
(Fig. 1).

400
C
D
DT

Body weight

300

DL
DLT

200

*

*

*

*

Food and water intake
In nontreated diabetic rats (D group) food intake was significantly (P < 0.05) enhanced as compared with control
rats (C group). Both groups (DT, DL and DLT) had
lower food intake when compared to diabetic rats
(D group). However, only food intake was normalized in
diabetic rats with leucine supplementation (DL group)
(Table 2). In terms of water intake, the water intake of
the D group was significantly (P < 0.05) enhanced as
compared with C group, DT group, DL group, and DLT
group. No statistical differences (P > 0.05) were noted in
relation to the other groups (Table 2).

Muscle weight
After the 8 week experimental period, the absolute weight
of the EDL and GAS muscles were lower in the D group
compared to the C group (P < 0.05), indicating muscular
atrophy in this experimental model. Supplementation
with leucine and resistance training did not change the
absolute and relative weight of the EDL muscle of diabetic animals. However, there was no statistical difference
in the absolute weight of the GAS muscle in the DL, DT,
DLT groups compared with C group (P > 0.05), suggesting that leucine and/or resistance training may attenuate
the muscle mass loss detected in untreated diabetic animals. Moreover, the relative weight of the GAS (absolute
muscle weight/100 g of body weight) of the DT and DLT
groups was higher compared to the D group, and was
higher that the C group, demonstrating the anabolic effect
of resistance training (P < 0.05). There was no statistical
difference in the absolute and relative weights of SOL
between the experimental groups (P > 0.05), in the absolute and relative weights of SOL between the experimental
groups (P > 0.05), and between the DL and D groups in
the relative weight of the assessed muscles; in other
words, chronic supplementation of leucine did not affect
this parameter in diabetic rats (Table 2).

Glucose and insulin on serum
100

0
4

5

6

7

8

9

10

11

12

Age (week)

Figure 1. Changes in body weight between eight time-points
within each group during the 8 weeks of the experiment (n = 8 per
group). C: nondiabetic control group; D: diabetic group; DT:
resistance training group; DL: leucine supplementation group; DLT:
leucine supplementation plus resistance training group. *P < 0.05 C
group vs. D group.
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The D group had higher fasting glucose compared to
other groups, with DT, DL, and DLT showing significant
improvements in this outcome (P < 0.05). With respect
to serum insulin levels, the D group presented impaired
fasting insulin compared with nondiabetic rats
(P < 0.05). Supplementation of leucine and resistance
training improved fasting insulin (P < 0.05). Although no
statistical difference was noted between the diabetic animals, the DT, DL and DLT groups modestly increased
insulin compared to the D group. These data are shown
in Table 2.
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Table 2. Characteristics of the male rats.
Groups

C

D

EDL (g)
EDL (g/100 g)
GAS (g)
GAS (g/100 g)
SOL (g)
SOL (g/100 g)
Glucose (mg/dl)
Insulin (pg/ml)
Food Intake (g/24 h)
Water Intake (ml/24 h)
EDL Protein (mg/g body weight)

























0.137
0.040
1.591
0.470
0.116
0.035
85.89
3022
15.1
33.2
0.0910

0.002
0.000
0.027
0.007
0.004
0.000
7.29
406
5.27
3.28
0.002

0.106
0.039
1.365
0.467
0.101
0.085
310.8
1362
42.8
85.14
0.0639

DT
$

0.007
0.002
0.072$
0.009
0.005
0.046
57.38$
282$
5.91$
27.54$
0.006$

0.115
0.040
1.565
0.545
0.116
0.0417
175.5
2183
30.1
41.65
0.0967













DL
$

0.002
0.001
0.54
0.007$#
0.002
0.002
10.18#
576
2.73$#
5.11#
0.003#

DLT

0.114  0.003
0.041  0.001
1.502  0.047
0.500  0.007*
0.112  0.004
0.037  0.000
181.8  21.11#
1622  399
17.9  6.04#
26.21  1.96#
0.0773  0.000
$

0.114
0.043
1.502
0.570
0.112
0.040
176.5
1911
22.6
27.62
0.1041













0.002$
0.000
0.047
0.024$#
0.007
0.000
27.78#
320
2.27$#
1.98#
0.011#

Muscle weights in g and g/100 g. Glucose and insulin represents at the last week post euthanasia measured in 6-h-fasted. Food and water
intake for the last week of experiment. C: nondiabetic control group; D: diabetic group; DT: resistance training group; DL: leucine supplementation group; DLT: leucine supplementation plus resistance training group (n = 8 per group).
$
Vs. C Group (P < 0.05).
#
Vs. D Group (P < 0.05).
*Vs. DLT Group (P < 0.05).

Total protein in EDL muscle concentration
Muscle protein content is reported as mg/g of body
weight (Adams and Haddad 1996). The muscle protein
content in C, DT, and DLT groups were significantly
greater as compared with D (P < 0.05), but no difference
was observed between DT and DLT.

Functional performance tests
To evaluate the effects of training and leucine supplementation on muscle performance, grip strength and ambulation tests were administered. Results for these data are
presented in Figure 2. Resistance training (alone or
combined) showed statistically greater functional
improvements when compared to the D group (grip
strength – Fig. 2A, P < 0.05 and footprint length and
width – Fig. 2B and C, respectively, P < 0.05). These
results suggest that leucine supplementation alone was
able to significantly mitigate the loss of strength in diabetic rats, but resistance training was superior for promoting gains in muscle strength in comparison with
leucine-supplemented animals, as shown in Figure 2A
(P < 0.05). With respect to the 1-repetition maximum
(1RM) on the amparate (ladder), the DL group increased
strength by 12% increase while the DLT and DT groups
showed increases of 102% and 101%, respectively, compared to the D group (data not shown). In the ambulation test, DLT was the only group in which there was
attenuation of the motor function worsening in terms of
length between its steps when compared to group D. The
DT and DLT groups had greater width between their

steps when compared to the group D, and this parameter
was superior in DLT compared with DL (P < 0.05). Once
again, these results indicate that resistance training was
fundamental for improvement of physical and motor
function in diabetic animals.

Protein expression with relation to muscle
protein synthesis
To elucidate potential mechanisms responsible for the
anabolic effect of leucine and resistance training on STZinduced muscle atrophy, we measured mTOR and
p70S6K protein levels in EDL muscles. In nontreated diabetic rats phosphoSer2448/total mTOR ratio and phosphoThr389/total p70S6K ratio protein was reduced when
compared to the control group (C group) and the DT
and DLT groups (P < 0.05). Therefore, resistance training
enhanced recovery of mTOR and p70S6K proteins
(P < 0.05), but leucine alone did not affect these parameters (Fig. 3A and B).

Discussion
This study investigated the effects of chronic supplementation with leucine and resistance training on diabetic
myopathy in experimental diabetes mellitus induced by
streptozotocin. Our results showed that resistance training
alone or combined with leucine minimized the deleterious
effects of diabetes mellitus on skeletal muscle as determined by an enhanced physical functional capacity muscle as well as improvements in certain metabolic
parameters such as fasting glucose and insulin. These
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0
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c
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5
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4
3
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a
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0.0
C

D
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DLT

β -actin

0.8

b

b
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0.6
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0.4

a

0.2
0.0
C

D

DT

DL

DLT

Figure 3. Effects of leucine supplementation and resistance
training on protein expression with relation to muscle protein
synthesis. (A) Representative blots show the effect of leucine and
resistance training on the EDL muscle phospho/total ratio of mTOR,
(B) phospho/total ratio of p70S6K. C: nondiabetic control group; D:
diabetic group; DT: resistance training group; DL: leucine
supplementation group; DLT: leucine supplementation plus
resistance training group. N = 8 per group. Means with different
letters are significantly different (P < 0.05).

ab

a
2
1
0
3

ab

1.0

Phospho - p70S6KThr389

0

C

1.5

b

b

b

Total - p70S6K

ab

10

3

2.0

B

b

Phospho Thr389/total p70S6K ratio
(Arbitrary units)

Print length (cm)

B

Total - mTOR

PhosphoSer2448/total mTOR ratio
(Arbitrary units)

A

11
Age (week)

Figure 2. Functional performance tests. (A) grip meter (N); (B)
ambulation (length in cm); (C) ambulation (width in cm). C:
nondiabetic control group; D: diabetic group; DT: resistance
training group; DL: leucine supplementation group; DLT: leucine
supplementation plus resistance training group. N = 8 per group.
Means with different letters are significantly different (P < 0.05).

results appear to be mediated by an increased activation
of the molecular signaling pathways involved in MPS.
In diabetes mellitus, muscle atrophy associated with
diabetic myopathy may be the result of reduced MPS
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and/ or exacerbated increase in muscle protein breakdown. It is known that skeletal muscle is approximately
40% of the total body mass (Frontera and Ochala 2015),
thus, any degenerative disorder leading to muscle atrophy
is associated with a decrease in quality of life along with
an increased risk of morbidity and mortality (Goodman
et al. 2011; Srikanthan and Karlamangla 2014).
The results of this study show that combined resistance
training with leucine supplementation recovered the activity of the mTOR-p70S6K pathway in diabetic animals,
which may reflect greater MPS. This suggests that the anabolic stimulation of resistance training is the predominant
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factor in the activation of this pathway in diabetic animals,
and leucine may enhance this effect as a substrate for muscle protein translation. Evidence shows that leucine
directly activates mTOR after a resistance training bout.
Pasiakos et al. (2011) demonstrated that leucine supplementation after exercise increased MPS by 33% in conjunction with heightened intracellular signaling. Similarly,
Dreyer et al. (2008) found that a leucine-enriched supplement provided after resistance training increased both
mTOR signaling and mixed muscle protein synthesis.
Resistance training induces muscle hypertrophy via a
sequential cascade consisting of: (1) activation of muscle
fibers; (2) signaling pathway activation resulting from the
mechanical deformation of the muscle fibers; (3) release
of hormones and myokines involved in the immune/inflammatory response; (4) an increased MPS from the activation of protein transcription and translation, (5) an
increase in the cross-sectional area of muscle fibers (Baar
and Esser 1999; Kubica et al. 2005; Spiering et al. 2008;
Ogasawara et al. 2013). The load-induced activation of
mTOR has been shown to be a critical component in this
hypertrophic cascade (Burd et al. 2010; Goodman et al.
2011). Thus, the influence of resistance training on the
activation of the mTOR-p70S6K pathway would appear
to explain functional improvements in diabetic animals
that performed resistance training.
In our study, supplementation of leucine (without
mechanical stimulation of resistance training) did not significantly affect the mTOR-p70S6K pathway. It is possible
that the duration of treatment or the amount of leucine
provided in the diet was lower than necessary to overcome muscle anabolic resistance in diabetes. Leucine
stands out among the essential amino acids for its ability
to stimulate protein translation and subsequently increase
the MPS rate and muscle growth (Norton and Layman
2006; Kelleher et al. 2013). However, the dosages of leucine must be sufficiently high to promote optimal anabolic effects and thus mediate the synthesis of
myofibrillar proteins, which are impaired in DM (Manders et al. 2012). In diabetes, ketoacidosis increases the
branched chain amino acid oxidation rate by the
branched-chain a-ketoacid dehydrogenase enzyme, particularly leucine, and the inflammatory state increases protein degradation rates (Workeneh and Bajaj 2013). This
phenomenon may have hindered the effect of leucine on
the activation of the mTOR -p70S6K in diabetic animals.
The activation of mTOR-p70S6K anabolic pathway
through resistance training combined with a diet supplemented with leucine was crucial to attenuate the skeletal
muscle atrophy in diabetic rats. Our findings showed no
statistical difference in the absolute weight of the gastrocnemius muscle of the DL, DT and DLT groups compared
with the C group, suggesting that leucine and resistance

Effects of Leucine Supplementation and Resistance Training

training can alleviate the muscle mass loss detected in
untreated diabetic animals. The relative weight of the gastrocnemius in the groups that underwent strength training (DT and DLT) increased approximately 16% and
22%, respectively, compared to the diabetic rats without
treatment (D group), which highlights the anabolic effect
of resistance training on the increase in muscle mass.
Although results were not statistically significant, the relative weight of the gastrocnemius muscle in the group that
only received leucine supplementation increased by 7%
compared with the D group. These data suggest that in
diabetic animals, the anabolic effects of leucine depend
on the mechanical stimulus of resistance training, unlike
what occurs in healthy subjects (Zanchi et al. 2012).
Supplementation with leucine and resistance training
(alone or combined) did not alter the absolute and relative weights of the EDL muscle and body mass. It is conceivable that the null findings may be attributed to the
short study period (8 weeks); a small muscle such as the
EDL may require a longer intervention time for significant muscle hypertrophy to be observed. On the other
hand, protein concentrations of EDL in C, DT and DLT
rats were significantly increased compared with D group.
These changes may further suggest that resistance training
promotes protein accretion in EDL muscle, without
affecting variations in skeletal muscle.
With respect to functional and motor elements, resistance training alone or combined with leucine supplementation recovered muscle strength and significantly
improved ambulation capacity (length and width between
steps) in the diabetic animals. Our study showed that grip
strength was greater in DT and DLT groups compared
with the D group, with no statistical difference between
the trained groups and the C group, that is, the resistance
training increased muscle strength in diabetic rats, even
in absence of leucine. Similar findings were reported in
studies of Call et al. (2010) and Chen et al. (2014). On
the other hand, Kim et al. (2015) found that resistance
training did not improve grip strength in diabetic Zucker
rats. The reasons for the discrepancies between studies are
not clear.
Interestingly, we observed that supplementation with
leucine alone was able to attenuate the loss of muscle
strength of diabetic animals. However, the change in grip
strength of the DT group was greater than that of the DL
group, demonstrating that resistance training is the primary stimulus for promoting improvements in this
parameter. Contrary to our findings, Zanchi et al. (2012)
showed that a diet supplemented with leucine impaired
motor performance in mice with muscular atrophy
induced by dexamethasone.
Supplementation of leucine and resistance training
improved glycemia in diabetic animals. In our study, the
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treated diabetic animals (DT, DL, and DLT) showed
lower fasting and postprandial values compared to the D
group, with no statistical difference with the C group.
The findings demonstrate that these interventions were
able to normalize blood glucose levels in our experimental
diabetes model. Interestingly, supplementation of leucine
alone induced this effect on blood glucose levels in diabetic animals, similar to results found by Wilkinson et al.
(2013) in humans with type 2 diabetes. Moreover, when
administered in high doses, leucine supplementation may
impair insulin signaling and the uptake of glucose in
obese rats fed with a high-fat diet, as shown by Ham
et al. (2014). Due to the controversies over the role of
leucine in glucose homeostasis, more studies involving
this approach are needed to improve our understanding
of the topic.
In this study, untreated diabetic animals displayed
moderate hypoinsulinemia that is characteristic of diabetes in the experimental model used. Chronic supplementation of leucine and resistance training did not
reverse hypoinsulinemia in diabetic animals, but it was
able to improve the concentration of serum insulin in
these animals. Some studies have shown that the resistance training is able to increase insulin production and
secretion in isolated pancreatic islets of rats with uncompensated type 1 diabetes (Oliveira et al. 2010; Huang
et al. 2011). Moreover, resistance training increases insulin sensitivity in peripheral tissues such as skeletal muscle
and glucose uptake, with these effects persisting for up to
24–48 h after an exercise session (Holten et al. 2004;
Cartee 2015).
Interestingly, we observed that supplementation of
leucine alone was able to improve the serum insulin in
diabetic animals. This may be explained by the effects
of leucine as an insulin secretagogue, which occurs
through two potential mechanisms: leucine undergoes
deamination to then produce alpha-ketoisocaproate
(Gao et al. 2003) or it allosterically activates the
enzyme glutamate dehydrogenase (Smith and Stanley
2008). Both mechanisms increase the intracellular ATP/
ADP ratio and cause the release of insulin (rapid phase
secretion of this hormone). This improvement in the
concentration of serum insulin in diabetic animals after
chronic supplementation of leucine may also have contributed to these animals presenting lower blood sugar
levels.
In addition, leucine supplementation as well as resistance training was able to reduce clinical symptoms such
as polyphagia and polydipsia present in diabetes. Studies
in animals and humans suggest that leucine acts as a
nutrient indicator to reduce calorie intake, either by activating mTOR, by increasing concentrations of cholecystokinin, or moderately decreasing antral pressures (Cota
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et al. 2006; Blouet and Schwartz 2012; Steinert et al.
2015). Strength training in humans can reduce the intake
of fat and calories after 8 months of training (Bales et al.
2012).
This study provides important information for the
development of nonpharmacological strategies for the
treatment of diabetes mellitus, particularly in diabetic
individuals that depend on exogenous insulin. Note that
exogenous insulin alone is not sufficient to stimulate
MPS in the postprandial state, which requires a greater
intake of protein through a diet supplemented with essential amino acids rich in leucine. In combination with regimented resistance training, this strategy helps to maintain
and build strong muscles and bones.

Conclusions
It can be concluded that chronic leucine supplementation
and resistance training are effective in improving muscle
strength and normalizing fasting plasma glucose and the
postprandial phase in diabetic animals. However, resistance training was responsible for major functional adaptations in skeletal muscle of diabetic rats, promoting
greater increases in strength and muscle mass compared
to leucine supplementation alone. However, the combination of both resistance training and leucine appear to
have synergistic effects on MPS, conceivably by regulating
the mTOR-p70S6K pathway.
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